| Variables |
Treatment group (with TXA and MBLPA) (n=44) |
Control group (without TXA or MBLPA) (n=43) |
P value | ||
|---|---|---|---|---|---|
|
Mean ± SD n(%) |
(Max-Min) |
Mean ± SD n(%) |
(Max-Min) | ||
| Age | 68.8±9.2 | (33.0-81.6) | 74.2±7.2 | (60.0-90.6) | 0.002† |
| Weight | 79.2±12.9 | (53.0-108.1) | 77.9±18.2 | (50.0-168.0) | 0.376* |
| Female sex | 32 (73%) | 32 (74%) | 0.526‡ | ||
| BMI | 30.9± 4.5 | (23.4-41.9) | 29.8± 6.7 | (18.8-61.7) | 0.097* |
| BMI category | |||||
| Normal-preobesity | 17 (41%) | 20 (51%) | 0.745‡ | ||
| Obesity II | 23 (56%) | 18 (46%) | |||
| Obesity III | 1 (2%) | 1 (3%) | |||
| ASA | 2.3±0.5 | (1.0-3.0) | 2.5±0.5 | (2.0-3.0) | 0.106† |
| ASA category | |||||
| I | 1 (2%) | 0 -- | 0.183‡ | ||
| II | 28 (67%) | 23 (53%) | |||
| III | 13 (31%) | 20 (47%) | |||
| Preoperative haemoglobin (g/dL) | 14.1±1.0 | (12.6-16.7) | 13.8±1.3 | (11.1-16.6) | 0.180† |
| Haemoglobin category | |||||
| >13 | 40 (91%) | 29 (69%) | 0.019‡ | ||
| 12-13 | 4 (9%) | 10 (24%) | |||
| <12 | -- -- | 3 (7%) | |||
| Preoperative haematocrit (%) | 43.1±2.8 | (38.3-49.5) | 42.0±3.8 | (34.7-49.3) | 0.113† |